Diabetic sensorimotor peripheral neuropathy (DSPN) is a serious complication of diabetes
mellitus and is associated with increased mortality, lower-limb amputations and distressing …

Pre-diabetes and diabetes are a global epidemic, and the associated neuropathic
complications create a substantial burden on both the afflicted patients and society as a …

Diabetic neuropathies (DNs) differ in clinical course, distribution, fiber involvement (type and
size), and pathophysiology, the most typical type being a length-dependent distal symmetric …

Diabetic autonomic neuropathy (DAN) is a serious and common complication of diabetes.
Despite its relationship to an increased risk of cardiovascular mortality and its association …

Peripheral neuropathy is a severe dose limiting toxicity associated with cancer
chemotherapy. Ever since it was identified, the clear pathological mechanisms underlying …

This review summarises the results and discussions of an UNESCO‐MCBN supported
symposium on oxidative stress and its role in the onset and progression of diabetes. There is …

Diabetes mellitus is a major cause of peripheral neuropathy, commonly manifested as distal
symmetrical polyneuropathy. This review examines evidence for the importance of vascular …

Aims To determine the efficacy and safety of 600 mg of α‐lipoic acid given intravenously
over 3 weeks in diabetic patients with symptomatic polyneuropathy. Methods We searched …

α-Lipoic acid (LA) and its reduced form, dihydrolipoic acid, are powerful antioxidants. LA
scavenges hydroxyl radicals, hypochlorous acid, peroxynitrite, and singlet oxygen …

OBJECTIVE: To evaluate the efficacy and safety of alpha-lipoic acid given intravenously,
followed by oral treatment in type 2 diabetic patients with symptomatic polyneuropathy …